Answers are grounded in this paper and cite their sources.
Introduction: Precision oncology has broadened the spectrum of oral adverse drug reactions (ADRs), while combination regimens and common oral diseases complicate their recognition and attribution. Objectives: To propose a phenotype-first framework for assessing suspected oral ADRs, guiding triage and management, and supporting anticancer treatment continuity. Methods: A manual literature search was conducted in PubMed/MEDLINE and Google Scholar using combinations of keywords such as “oral adverse drug reactions,” “oral toxicity,” “precision oncology,” “immune checkpoint inhibitors,” “targeted therapy,” “oral mucositis,” “xerostomia,” “medication-related osteonecrosis of the jaw,” “oral lichenoid reactions,” and “supportive care.” Relevant studies and clinical guidelines were synthesized narratively to develop a phenotype-first framework. Results: The framework considers lesion morphology and functional impact alongside treatment chronology, host factors, local dental conditions, targeted investigations, and response to intervention. It addresses immune-inflammatory and lichenoid disease, aphthous-like or mucositis-like ulceration, salivary and taste dysfunction, secondary infection, and impaired wound or bone healing. Combining phenotype with diagnostic certainty and clinical severity informs proportionate action, from local supportive care and reassessment to urgent specialist evaluation and oncology coordination. Structured documentation and patient-reported outcomes can support longitudinal assessment and pharmacovigilance. Conclusion: Phenotype-first reasoning may help clinicians distinguish suspected treatment toxicity from competing or coexisting oral conditions and manage reversible symptoms without unnecessarily disrupting cancer therapy. Severe, persistent, atypical, or diagnostically uncertain findings require timely interdisciplinary assessment. Prospective evaluation is needed to establish the framework’s reproducibility and clinical utility.
No takes yet. Share an insight, caveat, or question.
Polizzi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: